Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-20 Sale |
2021-12-22 9:51 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
1,915 | $123.84 | $237,154 | 8,240 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-22 9:51 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
12,000 | $125 | $1,500,000 | 0 (Direct) |
View |
| 2021-12-14 Sale |
2021-12-16 9:04 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
28,858 | $105.37 | $3,040,889 | 54,649 (Indirect Direct) |
View |
| 2021-12-10 Sale |
2021-12-10 8:43 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
35,000 | $102.55 | $3,589,146 | 94,988 (Direct) |
View |
| 2021-11-29 Sale |
2021-12-01 7:24 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
24,525 | $112.8 | $2,766,433 | 1,496,650 (Indirect Direct) |
View |
| 2021-11-16 Sale |
2021-11-17 7:03 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
37,740 | $116.65 | $4,402,385 | 1,521,175 (Indirect Direct) |
View |
| 2021-11-10 Purchase |
2021-11-10 6:19 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
5,000 | $122.87 | $614,342 | 2,560,801 (Indirect Direct) |
View |
| 2021-03-17 Purchase |
2021-03-17 5:13 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
13,157 | $76 | $999,932 | 2,555,801 (Indirect Direct) |
View |
| 2020-06-17 Sale |
2021-03-05 8:54 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
4,000 | $72.15 | $288,610 | 4,009 (Direct) |
View |
| 2021-03-02 Purchase |
2021-03-03 9:22 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
10,000 | $85.14 | $851,370 | 2,542,644 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-06 Tax Withholding |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
1,800 | $123.86 | 58,153 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
3,750 | $0 | 58,153 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:17 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
39,000 | $0 | 58,153 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor |
1,532 | $123.86 | 71,923 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor |
7,000 | $0 | 71,923 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor |
1,279 | $128.87 | 71,923 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:17 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor |
39,000 | $0 | 71,923 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
1,838 | $123.86 | 81,277 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
35,250 | $0 | 81,277 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
1,539 | $128.87 | 81,277 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:17 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
17,000 | $0 | 81,277 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
2,230 | $123.86 | 80,249 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
8,750 | $0 | 80,249 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
1,631 | $128.87 | 80,249 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:16 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
45,000 | $0 | 80,249 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
5,854 | $123.86 | 1,122,714 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
22,500 | $0 | 1,122,714 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
4,634 | $128.87 | 1,122,714 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:16 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
110,000 | $0 | 1,122,714 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 9:30 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
12,500 | $0 | 43,677 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 9:30 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
6,323 | $137.81 | 43,677 (Direct) |
View |
| 2021-12-20 Option Award |
2021-12-22 9:52 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
3,417 | $0 | 3,417 (Direct) |
View |
| 2021-12-20 Option Award |
2021-12-22 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director |
3,320 | $0 | 3,320 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 9:51 pm |
N/A 2027-08-01 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
12,000 | $0 | 0 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
12,000 | $23.63 | 0 (Direct) |
View |
| 2021-12-14 Exercise |
2021-12-16 9:04 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
18,500 | $10.82 | 54,649 (Direct) |
View |
| 2021-12-14 Exercise |
2021-12-16 9:04 pm |
N/A 2027-12-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
28,858 | $0 | 54,649 (Direct) |
View |
| 2021-12-14 Exercise |
2021-12-16 9:04 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
10,358 | $20.79 | 54,649 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-14 8:52 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-10 8:43 pm |
N/A 2027-01-30 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
35,000 | $0 | 94,988 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:33 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
1,250 | $0 | 6,281 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:33 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
492 | $115.55 | 6,281 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:33 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
3,375 | $0 | 13,029 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:33 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
1,599 | $115.55 | 13,029 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:32 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
3,000 | $0 | 11,822 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:32 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
1,305 | $115.55 | 11,822 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:30 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
3,750 | $0 | 13,453 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:30 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
1,738 | $115.55 | 13,453 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:29 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
3,700 | $0 | 14,896 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:29 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Chief Financial Officer |
1,715 | $115.55 | 14,896 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:28 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
10,950 | $0 | 956,364 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:28 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
5,075 | $115.55 | 956,364 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 4:26 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
1,915 | $32.42 | 29,950 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 4:26 pm |
N/A 2028-11-20 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
6,915 | $0 | 29,950 (Direct) |
View |
| 2021-11-26 Tax Withholding |
2021-11-26 4:26 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
2,318 | $115.55 | 29,950 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 4:26 pm |
N/A 2027-09-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
13,885 | $0 | 64,624 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 4:26 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
885 | $20.79 | 64,624 (Direct) |
View |
| 2021-11-23 Exercise |
2021-11-26 4:26 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
10,000 | $37.54 | 64,624 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
20,000 | $10.82 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
212,500 | $0.61 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
474,200 | $0 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
150,000 | $5.6 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
18,000 | $28.76 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
18,000 | $47.1 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
37,700 | $9.29 | 3,035,001 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
18,000 | $61.76 | 3,035,001 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
30,000 | $10.82 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
250,000 | $0.61 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A 2024-11-25 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
559,000 | $0 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
175,000 | $5.6 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $28.76 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $47.1 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
50,000 | $9.29 | 1,521,175 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-17 7:03 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
18,000 | $61.76 | 1,521,175 (Direct) |
View |
Ownership |
2021-08-13 8:44 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
0 | $0 | 63,393 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 9:51 pm |
N/A 2031-06-15 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
13,004 | $0 | 13,004 (Direct) |
View |
Ownership |
2021-06-17 9:50 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
0 | $0 | 47,515 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-07 4:34 pm |
N/A 2031-05-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
11,996 | $0 | 11,996 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-07 4:34 pm |
N/A 2031-05-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
11,996 | $0 | 11,996 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-07 4:34 pm |
N/A 2031-05-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
11,996 | $0 | 11,996 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-07 4:34 pm |
N/A 2031-05-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
11,996 | $0 | 11,996 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-07 4:33 pm |
N/A 2031-05-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
11,996 | $0 | 11,996 (Direct) |
View |
| 2021-05-05 Option Award |
2021-05-07 4:33 pm |
N/A 2031-05-04 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director |
11,996 | $0 | 11,996 (Direct) |
View |
| 2020-06-09 Option Award(A) |
2021-03-26 4:14 pm |
N/A 2030-06-09 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
18,948 | $0 | 18,948 (Direct) |
View |
| 2020-10-16 Ownership |
2021-02-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
2,500 | $0 | 462,841 (Indirect) |
View |
Ownership |
2021-02-12 9:51 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
0 | $0 | 462,841 (Direct) |
View |